St. Jude Medical Inc. (STJ)
-NYSE 46.78 
0.06(0.13%) 4:01PM EDT|After Hours
:
46.78 0.00 (0.00%) 4:25PM EDT
| Prev Close: | 46.72 |
|---|
| Open: | 46.91 |
|---|
| Bid: | 46.51 x 200 |
|---|
| Ask: | 46.96 x 200 |
|---|
| 1y Target Est: | 45.06 |
|---|
| Beta: | 1.3 |
|---|
| Next Earnings Date: | 15-Jul-13 |
|---|
| Day's Range: | 46.70 - 47.39 |
|---|
| 52wk Range: | 30.25 - 47.39 |
|---|
| Volume: | 2,863,893 |
|---|
| Avg Vol (3m): | 2,441,780 |
|---|
| Market Cap: | 13.26B |
|---|
| P/E (ttm): | 18.82 |
|---|
| EPS (ttm): | 2.49 |
|---|
| Div & Yield: | 1.00 (2.10%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- St Jude Medical Reaches New 52-Week High (STJ)at TheStreet(Tue 10:05AM EDT)
- InPlay: St. Jude Medical announces the start of its landmark EnligHTNment clinical studyBriefing.com(Tue 9:53AM EDT)
- St. Jude Medical EnligHTNment Study Highlighted at EuroPCR During Trials That May Change Clinical Practice SessionBusiness Wire(Tue 9:52AM EDT)
- Medtronic’s Heart Rhythm Devices Show Signs of Growthat Bloomberg(Tue 8:59AM EDT)
- St. Jude Medical to Present at the 38th Annual Deutsche Bank Health Care ConferenceBusiness Wire(Tue 8:00AM EDT)
- Will Obamacare Crush Medtronic's Earnings?at Motley Fool(Mon, May 20)
- Why This Big Buyback Isn't a Long-Term Solutionat Motley Fool(Fri, May 17)
- CE Mark for STJ's ILUMIEN OPTISZacks(Fri, May 17)
- St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent PlacementBusiness Wire(Thu, May 16)
- Today's 3 Best Stocksat Motley Fool(Wed, May 15)
- Health Services Stocks On The Rise With Help From 5 Stocksat TheStreet(Wed, May 15)
- Study for STJ's Latest EnligHTNZacks(Wed, May 15)
- Good News for STJ's DurataZacks(Tue, May 14)
- St. Jude Medical announces first patient enrolled in EnligHTN III studyat theflyonthewall.com(Tue, May 14)
- St. Jude Medical Announces First Patient Enrollment in EnligHTN III Renal Denervation Study of Next-Generation EnligHTN SystemBusiness Wire(Tue, May 14)
Key Statistics
| Forward P/E (1 yr): | 11.90 |
|---|
| P/S (ttm): | 2.43 |
|---|
| Ex-Dividend Date: | 26-Jun-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.70 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.94 |
|---|
| Mean Recommendation*: | 2.6 |
|---|
| PEG Ratio (5 yr expected): | 1.30 |
|---|
Business Summary
St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in two divisions, Cardiovascular and Ablation Technologies, and Implantable Electronic Systems.
View More